TSXV:ELXR

Stock Analysis Report

Executive Summary

Elixxer Ltd., an investment holding company, holds investments in private cannabis operations in Canada, Australia, Italy, Jamaica, and Switzerland.


Snowflake Analysis

Imperfect balance sheet and overvalued.

Share Price & News

How has Elixxer's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: ELXR's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

0%

ELXR

-0.1%

CA Capital Markets

2.1%

CA Market


1 Year Return

-73.9%

ELXR

-18.5%

CA Capital Markets

-21.2%

CA Market

Return vs Industry: ELXR underperformed the Canadian Capital Markets industry which returned -19.5% over the past year.

Return vs Market: ELXR underperformed the Canadian Market which returned -22.9% over the past year.


Shareholder returns

ELXRIndustryMarket
7 Day0%-0.1%2.1%
30 Day20.0%-22.0%-13.8%
90 Day-33.3%-23.7%-21.9%
1 Year-73.9%-73.9%-14.5%-18.5%-18.6%-21.2%
3 Year20.0%20.0%-7.8%-19.7%-11.0%-19.3%
5 Yearn/a2.9%-19.9%1.6%-13.6%

Price Volatility Vs. Market

How volatile is Elixxer's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Elixxer undervalued compared to its fair value and its price relative to the market?

0.75x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate ELXR's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate ELXR's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: ELXR is unprofitable, so we can't compare its PE Ratio to the Capital Markets industry average.

PE vs Market: ELXR is unprofitable, so we can't compare its PE Ratio to the Canadian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate ELXR's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: ELXR is good value based on its PB Ratio (0.8x) compared to the CA Capital Markets industry average (0.8x).


Next Steps

Future Growth

How is Elixxer forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

4.8%

Forecasted Diversified Financials industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Elixxer has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Elixxer performed over the past 5 years?

-38.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: ELXR is currently unprofitable.

Growing Profit Margin: ELXR is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: ELXR is unprofitable, and losses have increased over the past 5 years at a rate of -38.3% per year.

Accelerating Growth: Unable to compare ELXR's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ELXR is unprofitable, making it difficult to compare its past year earnings growth to the Capital Markets industry (-9.4%).


Return on Equity

High ROE: ELXR has a negative Return on Equity (-62.73%), as it is currently unprofitable.


Next Steps

Financial Health

How is Elixxer's financial position?


Financial Position Analysis

Short Term Liabilities: ELXR's short term assets (CA$1.9M) do not cover its short term liabilities (CA$7.0M).

Long Term Liabilities: ELXR has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: ELXR's debt to equity ratio (24.6%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if ELXR's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ELXR has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: ELXR has less than a year of cash runway if free cash flow continues to reduce at historical rates of -34.6% each year


Next Steps

Dividend

What is Elixxer's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate ELXR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate ELXR's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if ELXR's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ELXR's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of ELXR's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.3yrs

Average management tenure


CEO

Mazen Haddad (45yo)

1

Tenure

CA$463,943

Compensation

Mr. Mazen Haddad serves as the Chief Information Officer of Legal Research Center, Inc. Mr. Haddad served as an Interim Chief Executive Officer of Argex Titanium Inc. from December 18, 2015 to July 2016 an ...


Leadership Team

NamePositionTenureCompensationOwnership
Mazen Haddad
CEO & Director1yrCA$463.94k2.25% CA$378.9k
John A. McMullen
President3.17yrsCA$127.50k0.64% CA$107.8k
Ferras Zalt
Executive Chairman0.92yrno data1.41% CA$236.4k
Kym No
Corporate Controller & Interim CFO0.083yrno datano data
Remy Di Meglio
Chief Operating Officer1.5yrsno datano data
Guy Charette
Legal Councilno datano datano data
Jeanne van Wyk
Vice President of Communicationsno datano datano data
Daniel Lubienietzky
VP of Corporate Development1.67yrsno datano data
Richard Widmann
EVP of Commercial1yrno datano data
Michael Kozub
Corporate Secretary1.5yrsno datano data

1.3yrs

Average Tenure

53.5yo

Average Age

Experienced Management: ELXR's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Mazen Haddad
CEO & Director1yrCA$463.94k2.25% CA$378.9k
Ferras Zalt
Executive Chairman0.92yrno data1.41% CA$236.4k
David Lenigas
Director5.08yrsCA$153.76k10.46% CA$1.8m
Rafi Hazan
Director14.25yrsCA$48.00k0.12% CA$20.5k
Mohammed Ghafari
Independent Director3.33yrsCA$30.00k0.54% CA$90.0k

5.1yrs

Average Tenure

52.5yo

Average Age

Experienced Board: ELXR's board of directors are considered experienced (5.1 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: ELXR insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 35.3%.


Top Shareholders

Company Information

Elixxer Ltd.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Elixxer Ltd.
  • Ticker: ELXR
  • Exchange: TSXV
  • Founded:
  • Industry: Asset Management and Custody Banks
  • Sector: Diversified Financials
  • Market Cap: CA$16.815m
  • Shares outstanding: 560.51m
  • Website: https://www.elixxer.com

Location

  • Elixxer Ltd.
  • 800 Place Victoria
  • Suite 3700
  • Montreal
  • Quebec
  • H4Z 1E9
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
QBATSXV (TSX Venture Exchange)COMCACADNo data
ELXRTSXV (TSX Venture Exchange)YesCommon SharesCACADJul 2016
2LQADB (Deutsche Boerse AG)YesCommon SharesDEEURJul 2016
ELIX.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDJul 2016

Biography

Elixxer Ltd., an investment holding company, holds investments in private cannabis operations in Canada, Australia, Italy, Jamaica, and Switzerland. The company was formerly known as LGC Capital Ltd. and changed its name to Elixxer Ltd. in August 2019. Elixxer Ltd. is based in Montreal, Canada. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/04/08 07:52
End of Day Share Price2020/04/07 00:00
Earnings2019/09/30
Annual Earnings2019/09/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.